FDA to Hold Public Hearing on Regulation of Rare Disease Treatments

Summary

The Food and Drug Administration (FDA) is hosting a public hearing to gather input from healthcare providers, academia, industry, and patients on the regulation of drugs and devices for rare diseases, with the goal of informing the development of medical products for these conditions.